Literature DB >> 25612496

Heterogeneity and disparities in the use of exception scores in pediatric liver allocation.

E K Hsu1, M Shaffer, M Bradford, N Mayer-Hamblett, S Horslen.   

Abstract

Physicians apply for Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception points on a case-by-case basis to improve an individual patient's chances of receiving a liver transplant. This retrospective cohort study describes trends in the use of exceptions among the pediatric liver waitlist population with chronic liver disease. The cohort (n = 3728) included all children with a diagnosis of chronic liver disease listed in the United Network for Organ Sharing transplant database for first isolated liver transplant between February 27, 2002 and March 31, 2013. Exception score requests were common (34%); 90% of requests were approved. The rate of exception score requests in 2013 was five times that of 2002 (incident rate ratios [IRR] 5.25, 95% confidence interval [CI] 3.19-8.63, p < 0.01). Patients of non-White race had exception score request rates 13% lower than patients of White race (IRR 0.87, 95% CI 0.77-0.98, p = 0.02). Older patients had lower rates of exception score requests than younger patients (p = 0.03). Request rates varied by region. Time spent at an active exception status nearly tripled the hazard rate for transplantation (hazard ratio = 2.90, 95% CI 2.62-3.21, p < 0.01). There is disparity in use of exceptions by race that is not explained by clinical disease severity, diagnosis, geography or other demographic factors. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; disparities; ethics and public policy; liver transplantation/hepatology; organ allocation; pediatrics

Mesh:

Year:  2015        PMID: 25612496     DOI: 10.1111/ajt.13089

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  14 in total

1.  Justifying Nonstandard Exception Requests for Pediatric Liver Transplant Candidates: An Analysis of Narratives Submitted to the United Network for Organ Sharing, 2009-2014.

Authors:  E R Perito; H J Braun; J L Dodge; S Rhee; J P Roberts
Journal:  Am J Transplant       Date:  2017-02-28       Impact factor: 8.086

Review 2.  Save the Children: The Ethical Argument for Preferential Priority to Minors in Deceased Donor Liver Allocation.

Authors:  Evelyn Hsu; Emily R Perito; George Mazariegos
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

3.  A 10-Year united network for organ sharing review of mortality and risk factors in young children awaiting liver transplantation.

Authors:  Daniel H Leung; Amrita Narang; Charles G Minard; Girish Hiremath; John A Goss; Ross Shepherd
Journal:  Liver Transpl       Date:  2016-11       Impact factor: 5.799

4.  Predicting ideal outcome after pediatric liver transplantation: An exploratory study using machine learning analyses to leverage Studies of Pediatric Liver Transplantation Data.

Authors:  Sharad Indur Wadhwani; Evelyn K Hsu; Michele L Shaffer; Ravinder Anand; Vicky Lee Ng; John C Bucuvalas
Journal:  Pediatr Transplant       Date:  2019-07-22

5.  A learning health network for pediatric liver transplantation: Inaugural meeting report from the Starzl Network for Excellence in Pediatric Transplantation.

Authors:  James E Squires; Beth Logan; Angela Lorts; Henrisa Haskell; Kristen Sisaithong; Tony Pillari; Jonathan Szolna; Darcy Dodd; Regino P Gonzalez-Peralta; Evelyn Hsu; Beau Kelly; Beverly Kosmach-Park; Steven Lobritto; Vicky L Ng; Emily Perito; Sara Rasmussen; Rene Romero; Eyal Shemesh; Hannah Karolak; George V Mazariegos
Journal:  Pediatr Transplant       Date:  2019-07-22

6.  Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation.

Authors:  Douglas B Mogul; Xun Luo; Eric K Chow; Allan B Massie; Tanjala S Purnell; Kathleen B Schwarz; Andrew M Cameron; John F P Bridges; Dorry L Segev
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-03       Impact factor: 2.839

7.  Disparities in Waitlist and Posttransplantation Outcomes in Liver Transplant Registrants and Recipients Aged 18 to 24 Years: Analysis of the UNOS Database.

Authors:  Noelle H Ebel; Evelyn K Hsu; Kristin Berry; Simon P Horslen; George N Ioannou
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

8.  Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.

Authors:  Sonja M Swenson; John P Roberts; Sue Rhee; Emily R Perito
Journal:  Am J Transplant       Date:  2019-09-03       Impact factor: 8.086

9.  Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era.

Authors:  M G Bowring; L M Kucirka; A B Massie; X Luo; A Cameron; M Sulkowski; K Rakestraw; A Gurakar; I Kuo; D L Segev; C M Durand
Journal:  Am J Transplant       Date:  2016-08-24       Impact factor: 8.086

Review 10.  Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care.

Authors:  Shikha S Sundaram; Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Liver Transpl       Date:  2017-01       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.